Morten Karsdal
Company: Nordic Bioscience
Job title: Chief Executive Officer
Seminars:
Serological fibroblast & ECM biomarkers of Prognosis, Diagnosis, Efficacy of intervention & Prediction 10:00 am
Fibroblast activation is highly prognostic for liver, kidney and heart outcomes Weight dependent and weight independent de-activation of fibroblasts Tissue formation and tissue degradation: Matching Patient endotypes to treatmentsRead more
day: Conference Day 2 Morning